Lukas Biomedical Inc.

Lukas Biomedical Inc. is a biotechnology and healthcare company based in New Taipei City, Taiwan, established in 2002. It specializes in developing and commercializing immune cell medical technology, primarily focusing on regenerative medicine and adjuvant therapies for cancer patients. The company is recognized for pioneering memory T cell-based treatments, utilizing cutting-edge cell culture techniques to enhance immune recognition and attack of cancer cells with minimal side effects, thereby supporting patient quality of life and reducing recurrence rates. Lukas Biomedical operates across several segments, including e-commerce, medical management, cell product research and distribution, pharmaceutical market development, and leasing medical equipment. Alongside its core biotech activities, the company also conducts wholesale and retail cosmetics business. Lukas Biomedical has a dedicated team of clinicians and researchers and maintains strategic partnerships to expand its cell therapy innovations in Taiwan and abroad. By collaborating with leading medical institutions and actively pursuing regulatory approvals and clinical trials, Lukas Biomedical plays a significant role in advancing personalized cancer therapies and shaping the future of immunocellular treatment in the region.